All terms in HP
Label | Id | Description |
---|---|---|
hematopoietic progenitor cell antigen CD34 (human) | PR_P28906 | [A CD34 molecule that is encoded in the genome of human.] |
CD34 molecule | PR_000001003 | [A protein that is a translation product of the human CD34 gene or a 1:1 ortholog thereof. It is a leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. It contains a single-pass transmembrane domain and that show distinct expression on early hematopoietic precursors and vascular-associated tissue. Acts as a scaffold that presents selectin carbohydrate ligands in a clustered, tissue specific manner to allow for higher avidity interactions between leukocytes and endothelial cells during the inflammatory process. In common with related sialomucins (endoglycan and podocalyxin), the extracellular region is dominated by an N-terminal mucin-like domain, which is densely substituted with sialylated O-linked carbohydrates. The mucin-like region is followed by a cysteine-containing and presumably globular domain. This domain may fold into an immunoglobulin-like structure as the positions of 2 of the cysteines are conserved in the C2 set of the immunoglobulin superfamily. The cytoplasmic domain is around 73-76 residues long and highly conserved.] |
CD34 (human) | gene_symbol_report | [A protein coding gene CD34 in human.] |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (human) | PR_P28907 | [An ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 that is encoded in the genome of human.] |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | PR_000001408 | [An ADP-ribosyl cyclase that is a translation product of the human CD38 gene or a 1:1 ortholog thereof.] |
CD38 (human) | gene_symbol_report | [A protein coding gene CD38 in human.] |
physical quality | PATO_0001018 | [A quality of a physical entity that exists through action of continuants at the physical level of organisation in relation to other entities.] |
positive regulation of vasculature development | GO_1904018 | [Any process that activates or increases the frequency, rate or extent of vasculature development.] |
regulation of vasculature development | GO_1901342 | [Any process that modulates the frequency, rate or extent of vasculature development.] |
positive regulation of developmental process | GO_0051094 | [Any process that activates or increases the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).] |
positive regulation of multicellular organismal process | GO_0051240 | [Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs.] |
vasculature development | GO_0001944 | [The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.] |
regulation of cholesterol esterification | GO_0010872 | [Any process that modulates the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.] |
regulation of steroid metabolic process | GO_0019218 | [Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving steroids.] |
cholesterol esterification | GO_0034435 | [A lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.] |
positive regulation of cholesterol esterification | GO_0010873 | [Any process that increases the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.] |
positive regulation of steroid metabolic process | GO_0045940 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving steroids.] |
positive regulation of cellular metabolic process | GO_0031325 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.] |
animal organ morphogenesis | GO_0009887 | [Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.] |
anatomical structure morphogenesis | GO_0009653 | [The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.] |